Oruka Therapeutics ORKA Q4 2025 narrower than expected loss pushes shares up two percent on positive investor sentiment KLA Corporation KLAC Recent Underperformance Upcoming Earnings and Valuation Outlook News Analysis Its literally going to break me Commuting is now unaffordable for some Ameri Is Gladstone LANDO stock building trend strength Smart Money Active 20260420